Middle East respiratory syndrome
[용어속성] Disease
COVID-19 extrapulmonary illness – special gastrointestinal and hepatic considerations
Review
[키워드] abdominal pain
anorexia
coronavirus disease-2019
Coronaviruses
COVID-19
diarrhea
gastrointestinal manifestations
hepatic manifestations
MERS-CoV
Middle East respiratory syndrome
nausea
SARS-CoV-1
SARS-CoV-2
Severe acute respiratory syndrome
vomiting
[DOI] 10.1016/j.disamonth.2020.101064 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.disamonth.2020.101064 PMC 바로가기 [Article Type] Review
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective
인간 코로나바이러스의 최근 발생: 의약 화학 관점
Review
[키워드] animals
antiviral agent
Antiviral agents
antivirals
approved
biochemical
Brain
cleaving
CoV
CoV infection
COVID‐19
CoVs
drug
effort
event
focus
functional
heart
Human
human coronavirus
humans
include
infect
Infection
intestinal
kidney
life cycle
main protease inhibitors
MERS
MERS‐CoV
Middle East
Middle East respiratory syndrome
Mild
outbreak
Perspective
polyprotein
polyproteins
protease
Proteases
Proteins
Replication
respiratory
RNA‐dependent RNA polymerase
SARS‐CoV‐1
SARS‐CoV‐2
SARS‐CoV‐1
SARS‐CoV‐2
spike glycoprotein
syndrome
target
therapy
These viruses
these viruses
transmitted
Vaccine
Viral
viral entry
viral replication
Viral RNA
viruses
[DOI] 10.1002/med.21724 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/med.21724 PMC 바로가기 [Article Type] Review
Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data
Article
[키워드] cardiovascular comorbidities
cardiovascular disease
COVID‐19
hypertension
Middle East respiratory syndrome
pooled analysis
Prevalence
Severe acute respiratory syndrome
[DOI] 10.1161/JAHA.120.016812 PMC 바로가기
[DOI] 10.1161/JAHA.120.016812 PMC 바로가기
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19: A Living Systematic Review of Multiple Streams of Evidence
환기 기술 및 COVID-19를 포함한 코로나바이러스 질병 전파 위험: 여러 증거 흐름에 대한 살아있는 체계적 검토
Article
[키워드] acute respiratory syndrome
adjusted
aerosol-generating procedure
aerosol-generating procedures
AGPs
animal
approach
benefit
breath
certainty
certainty of evidence
confounders
coronavirus
coronavirus disease
Coronavirus disease 2019
Coronavirus infections
COVID-19
Direct
eligible
Evidence
GRADE
Health care
Health care worker
health care workers
Health Organization
hospitalized patient
hospitalized patients
hypoxemic
Hypoxemic respiratory failure
IMV
Including
independent
Invasive mechanical ventilation
Laboratory
language
Mechanical
mechanical ventilation
MERS
Middle East
Middle East respiratory syndrome
Mortality
Multiple
NIV
Noninvasive ventilation
Other
oxygen
Oxygen therapy
Oxygenation
Patient
patients with SARS
PROSPERO
reduce
reduction in mortality
reported
respiratory
Respiratory failure
review
risk
Severe acute respiratory syndrome
stream
syndrome
systematic review
systematic reviews
technique
Transmission
treat
Ventilation
virus transmission
with COVID-19
World Health Organization
[DOI] 10.7326/M20-2306 PMC 바로가기 [Article Type] Article
[DOI] 10.7326/M20-2306 PMC 바로가기 [Article Type] Article
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
Review article
[키워드] ACE inhibitors
ACE-2
ACEangiotensin-converting enzyme
ACEIACE inhibitors
Acute lung injury/Acute respiratory distress syndrome
ADAlzheimer's disease
ALI/ARDSAcute lung injury/Acute respiratory distress syndrome
Alzheimer's disease
Angangiotensin
angiotensin
Angiotensin II receptor type 1
Angiotensin II Receptor Type 2
Angiotensin receptor blockers
Angiotensin-converting enzyme
ARBsAngiotensin receptor blockers
AT1RAngiotensin II receptor type 1
AT2RAngiotensin II receptor type 2
Aββ-amyloid
benefit
BKsBradykinins
Bradykinin receptor
Bradykinins
BRBradykinin receptor
caused
chloroquine/hydroxychloroquine
clinical study
components
Coronavirus disease 2019
COVID-19
COVID-19 pathogenesis
COVID-19coronavirus disease 2019
CQ/HCQChloroquine/Hydroxychloroquine
ECsEndothelial cells
Effect
effective
effort
endothelial cells
endothelial Nitric oxide synthase
Endothelin-1
eNOSendothelial Nitric oxide synthase
ET-1Endothelin-1
Evidence
fibrosis
fMLPformyl Methionyl-meucyl-proline
formyl Methionyl-meucyl-proline
G protein-coupled
Gastrin-releasing peptide
GM-CSFGranulocyte-macrophage colony-stimulating factor
GPCRG protein-coupled
granulocyte-macrophage colony-stimulating factor
GRPGastrin-releasing peptide
Heme oxygenase-1
HO-1heme oxygenase-1
humans
ILInterleukin
interleukin
MAPK/ERKMitogen-activated protein kinases/ Extracellular signal-regulated kinases
Mas receptor
MasRMas receptor
MCP-1monocyte chemoattractant protein-1
MERSMiddle East Respiratory Syndrome
Middle East respiratory syndrome
Mitogen-activated protein kinases/ Extracellular signal-regulated kinases
molecular mechanisms
monocyte chemoattractant protein-1
NADPHNicotinamide adenine dinucleotide phosphate (reduced form)
Natriuretic peptides
NEPiNeprilysin inhibitors
NEPNeprilysin
neprilysin
Neprilysin inhibitors
NF-kBNuclear factor kappa B
Nicotinamide adenine dinucleotide phosphate (reduced form)
nitric oxide
Non steroidal anti-inflammatory drugs
NONitric Oxide
NPsNatriuretic peptides
Nrf2nuclear factor erythroid 2–related factor 2
NSAIDsNon steroidal anti-inflammatory drugs
nuclear factor erythroid 2–related factor 2
nuclear factor kappa B
pandemic disease
pathophysiology
pathway
Peroxisome proliferator activator receptors
Phospholipase C beta/inositol trisphosphate
PLCb/IP3Phospholipase C beta/inositol trisphosphate
PNECsPulmonary neuroendocrine cells
PPARsPeroxisome proliferator activator receptors
protective effect
pulmonary inflammatory reaction
pulmonary neuroendocrine cells
RAS
RASRenin angiotensin system
reactive oxygen species
receptors
renin angiotensin system
Repurposed drug
researcher
ROSreactive oxygen species
SARS-CoV2
SARS-CoVsevere acute respiratory syndrome coronavirus
Selective estrogen receptor modulators
SERMsSelective estrogen receptor modulators
severe acute respiratory syndrome Coronavirus
severe pneumonia
Streptozotocin
STZStreptozotocin
suggested
targeting
TGF-β1Transforming growth factor- β1
therapeutic intervention
therapy
TNFTumor Necrosis Factor
Transforming growth factor- β1
treatment approaches
tumor necrosis factor
Vaccine
vascular endothelial growth factor
VEGFvascular endothelial growth factor
β-amyloid
[DOI] 10.1016/j.bcp.2020.114057 [Article Type] Review article
[DOI] 10.1016/j.bcp.2020.114057 [Article Type] Review article
Interplay between SARS-CoV-2 and the type I interferon response
SARS-CoV-2와 I형 인터페론 반응 간의 상호작용
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
addition
against SARS-CoV
animal models
antiviral molecules
boost
caused
cells
characterized
clinical trial
Combination
complex interplay
conserved
conserved IFN evasion strategies
contribute
coronavirus
coronavirus epidemic
Coronavirus-2
counteraction
COVID-19
COVID-19 pandemic
Cytokines
dendritic cells
early stage
early stages
Efficacy
exacerbated
form
highlighting
IFN
IFN treatment
IFN-I
IFN-I response
IFN-I treatment
IFN-Is
immune response
interferons
knowledge
mechanism
MERS
MERS-CoV
Middle East
Middle East respiratory syndrome
Middle East respiratory syndrome-related coronavirus
molecular mechanisms
outbreak
pDC-mediated IFN response
pDC-mediated IFN responses
pDCs
plasmacytoid dendritic cell
plasmacytoid dendritic cells
potential benefit
potential benefits
proinflammatory cytokines
respiratory
responsible
SARS-CoV
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2–infected cells
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
spatiotemporal regulation
the disease
therapeutic
type I interferon
type I interferons
Viral
viral infection
while
[DOI] 10.1371/journal.ppat.1008737 PMC 바로가기 [Article Type] Review
[DOI] 10.1371/journal.ppat.1008737 PMC 바로가기 [Article Type] Review
A Cell-Based Reporter Assay for Screening Inhibitors of MERS Coronavirus RNA-Dependent RNA Polymerase Activity
Article
[키워드] activity
acute respiratory syndrome
antiviral drug
antiviral therapeutics
caused
cell-based reporter assay
cells
composed
conserved
coronavirus
coronavirus disease
CoV
COVID-19
dose-dependent inhibition
exhibited
Favipiravir
HCV
infections
inhibit
inhibited
inhibitor
inhibitors
MERS
MERS-CoV
Middle East
Middle East respiratory syndrome
nine
Nsp12
nucleoside analog
Plasmid
platform
polymerase
RdRP
RdRp inhibitor
Remdesivir
reporter
ribavirin
RNA
RNA-dependent RNA polymerase
Screening
sequence homology
suggested
syndrome
tested
valacyclovir
Z-factor
zoonotic disease
[DOI] 10.3390/jcm9082399 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm9082399 PMC 바로가기 [Article Type] Article